Testosterone enanthate Completed Phase 3 Trials for Hypogonadism Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02504541 | Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism | |
| NCT02159469 | Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism |